Mechanisms of Ischaemic Strokes and Transient Ischaemic Attacks Despite Oral Anticoagulation in Patients With Atrial Fibrillation
| aut.relation.endpage | 51 | |
| aut.relation.issue | 1636 | |
| aut.relation.journal | New Zealand Medical Journal | |
| aut.relation.startpage | 44 | |
| aut.relation.volume | 139 | |
| dc.contributor.author | Mahawish, KM | |
| dc.contributor.author | Feigin, V | |
| dc.contributor.author | Krishnamurthi, R | |
| dc.contributor.author | White, HD | |
| dc.date.accessioned | 2026-06-23T01:40:59Z | |
| dc.date.available | 2026-06-23T01:40:59Z | |
| dc.date.issued | 2026-06-12 | |
| dc.description.abstract | Aims: The aim of this article was to characterise the mechanisms underlying “breakthrough” ischaemic stroke (IS) or transient ischaemic attack (TIA) despite oral anticoagulation in patients with atrial fibrillation (AF). Methods: We conducted a cross-sectional analysis of adults with non-valvular AF who experienced IS/TIA in the fifth Auckland Regional Community Stroke Study (ARCOS V: September 2020 to August 2021). Using clinical records, we collected data on demographics, comorbidities and peri-event anticoagulant dosing and intake. Anticoagulant adherence in the months preceding IS/TIA was categorised as good control if proportion of days covered (PDC) ≥80% for direct oral anticoagulant users or time in therapeutic range (TTR) ≥70% for warfarin users. IS/TIA mechanism was adjudicated using standardised criteria and classified as cardioembolic or non-cardioembolic, and patient characteristics were compared. Results: Among 179 patients (76/179 [43%] female), 138/179 events (77%) were adjudicated as cardioembolic, while the remainder were attributed to competing mechanisms. Compared with non-cardioembolic events, cardioembolic aetiology was associated with younger median age (72 vs 81 years), lower proportions with good anticoagulant control (87/138 [63%] vs 34/41 [83%], p=0.017) and higher rates of peri-event missed or under-dosing (90/138 [65%] vs 18/41 [44%], p=0.014). In multivariable analysis, good control was independently associated with higher odds of a non-cardioembolic mechanism (adjusted odds ratio 3.67 [95% confidence interval 1.35–9.99], p=0.011). Conclusion: Most breakthrough IS/TIA events on oral anticoagulation were either associated with anticoagulant under-exposure (in patients with a cardioembolic aetiology) or a competing mechanism rather than anticoagulant failure. These findings highlight the importance of careful assessment to inform appropriate secondary prevention strategies. | |
| dc.identifier.citation | New Zealand Medical Journal, ISSN: 0028-8446 (Print); 1175-8716 (Online), Pasifika Medical Association Group, 139(1636), 44-51. doi: 10.26635/6965.7380 | |
| dc.identifier.doi | 10.26635/6965.7380 | |
| dc.identifier.issn | 0028-8446 | |
| dc.identifier.issn | 1175-8716 | |
| dc.identifier.uri | http://hdl.handle.net/10292/21466 | |
| dc.language | eng | |
| dc.publisher | Pasifika Medical Association Group | |
| dc.relation.uri | https://nzmj.org.nz/journal/vol-139-no-1636/mechanisms-of-ischaemic-strokes-and-transient-ischaemic-attacks-despite-oral-anticoagulation-in-patients-with-atrial-fibrillatio | |
| dc.rights | Open Access. The New Zealand Medical Journal now offers free open access for all individuals that subscribe to the journal, giving subscribers 24/7 access to online content from 1999 to present. The NZMJ is fully available to individual subscribers and does not incur a subscription fee. | |
| dc.rights.accessrights | OpenAccess | |
| dc.subject | 11 Medical and Health Sciences | |
| dc.subject | General & Internal Medicine | |
| dc.subject | 32 Biomedical and clinical sciences | |
| dc.subject | 42 Health sciences | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Atrial Fibrillation | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Ischemic Attack, Transient | |
| dc.subject.mesh | Anticoagulants | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Cross-Sectional Studies | |
| dc.subject.mesh | Aged, 80 and over | |
| dc.subject.mesh | Ischemic Stroke | |
| dc.subject.mesh | Administration, Oral | |
| dc.subject.mesh | New Zealand | |
| dc.subject.mesh | Risk Factors | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Ischemic Attack, Transient | |
| dc.subject.mesh | Atrial Fibrillation | |
| dc.subject.mesh | Anticoagulants | |
| dc.subject.mesh | Administration, Oral | |
| dc.subject.mesh | Risk Factors | |
| dc.subject.mesh | Cross-Sectional Studies | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Aged, 80 and over | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | New Zealand | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Ischemic Stroke | |
| dc.title | Mechanisms of Ischaemic Strokes and Transient Ischaemic Attacks Despite Oral Anticoagulation in Patients With Atrial Fibrillation | |
| dc.type | Journal Article | |
| pubs.elements-id | 764477 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Mahawish et al._2026_Mechanisms of ischaemic strokes.pdf
- Size:
- 161.15 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
